Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 68.12
-1.76 (-2.52%)
Aug 11, 2026, 3:04 PM CST
Betta Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 421.01 | 429.98 | 471.68 | 752 | 731.28 | 791.99 |
Trading Asset Securities | 89.23 | 66 | 126.44 | 0.54 | - | 201.01 |
Cash & Short-Term Investments | 510.23 | 495.98 | 598.12 | 752.54 | 731.28 | 993 |
Cash Growth | -14.64% | -17.08% | -20.52% | 2.91% | -26.36% | -35.35% |
Accounts Receivable | 512.46 | 351.26 | 98.47 | 286.41 | 450.62 | 173.38 |
Other Receivables | 20.47 | 77.95 | 1.83 | 2.61 | 49.7 | 40.75 |
Receivables | 532.93 | 429.21 | 100.3 | 289.02 | 500.32 | 214.13 |
Inventory | 351.68 | 381.16 | 290.09 | 327.5 | 372.17 | 293.32 |
Prepaid Expenses | - | - | - | 0.2 | - | - |
Other Current Assets | 275.64 | 271.48 | 235.82 | 156.62 | 129.06 | 153.49 |
Total Current Assets | 1,670 | 1,578 | 1,224 | 1,526 | 1,733 | 1,654 |
Property, Plant & Equipment | 2,926 | 2,962 | 3,009 | 2,574 | 2,056 | 1,331 |
Long-Term Investments | 2,539 | 2,583 | 1,437 | 1,382 | 919.27 | 345.79 |
Goodwill | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 |
Other Intangible Assets | 2,749 | 2,604 | 2,776 | 1,944 | 1,219 | 1,183 |
Long-Term Accounts Receivable | - | 13.28 | 9.29 | - | - | - |
Long-Term Deferred Tax Assets | 59.48 | 59.13 | 56.73 | 39.13 | 85.96 | 55.06 |
Long-Term Deferred Charges | 227.04 | 220.16 | 383.53 | 1,219 | 1,444 | 1,252 |
Other Long-Term Assets | 103.4 | 133 | 32.7 | 50.3 | 39.3 | 37.6 |
Total Assets | 10,688 | 10,566 | 9,342 | 9,147 | 7,910 | 6,271 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 417.94 | 512.32 | 746.11 | 800.12 | 35.85 | 431.19 |
Accrued Expenses | 90.65 | 390.16 | 285.53 | 357.82 | 419.11 | 357.02 |
Short-Term Debt | 5.03 | 5 | 100.08 | 300.27 | 380.39 | - |
Current Portion of Long-Term Debt | 801.39 | 824.19 | 639.85 | 301.25 | - | - |
Current Portion of Leases | - | 46.65 | 33.03 | 4.6 | 4.16 | 4.88 |
Current Income Taxes Payable | 94.9 | 47.24 | 4.26 | 0.07 | 0.04 | 10.68 |
Current Unearned Revenue | 5.31 | 2.37 | 2.63 | 4.92 | 4.46 | 0.69 |
Other Current Liabilities | 271.21 | 89.36 | 36.47 | 34.11 | 1,261 | 84.4 |
Total Current Liabilities | 1,686 | 1,917 | 1,848 | 1,803 | 2,105 | 888.86 |
Long-Term Debt | 1,703 | 1,524 | 1,552 | 1,816 | 656.03 | - |
Long-Term Leases | 51.21 | 62.84 | 71.63 | 8.18 | 7.3 | 6.34 |
Long-Term Unearned Revenue | 184.36 | 226.22 | 150.99 | 144.7 | 112.76 | 112 |
Long-Term Deferred Tax Liabilities | 162.49 | 167.91 | 53.49 | 23.39 | 71.57 | 68.39 |
Other Long-Term Liabilities | 37.74 | - | - | - | - | 510.06 |
Total Liabilities | 3,826 | 3,898 | 3,676 | 3,795 | 2,952 | 1,586 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 |
Additional Paid-In Capital | 2,168 | 2,164 | 2,076 | 2,142 | 1,860 | 1,932 |
Retained Earnings | 3,292 | 3,056 | 2,834 | 2,503 | 2,181 | 2,139 |
Comprehensive Income & Other | 914.47 | 954.47 | 245.21 | 188.3 | 390.99 | 74.64 |
Total Common Equity | 6,795 | 6,595 | 5,574 | 5,251 | 4,849 | 4,561 |
Minority Interest | 67.78 | 72.53 | 92.3 | 100.4 | 108.64 | 124.9 |
Shareholders' Equity | 6,863 | 6,668 | 5,666 | 5,351 | 4,958 | 4,686 |
Total Liabilities & Equity | 10,688 | 10,566 | 9,342 | 9,147 | 7,910 | 6,271 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | 2,561 | 2,462 | 2,396 | 2,430 | 1,048 | 11.22 |
Net Cash (Debt) | -2,051 | -1,966 | -1,798 | -1,678 | -316.59 | 981.77 |
Net Cash Growth | - | - | - | - | - | -35.97% |
Net Cash Per Share | -4.89 | -4.70 | -4.29 | -4.00 | -0.76 | 2.36 |
Filing Date Shares Outstanding | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 |
Total Common Shares Outstanding | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 |
Working Capital | -15.94 | -339.45 | -623.63 | -277.28 | -371.95 | 765.08 |
Book Value Per Share | 16.15 | 15.68 | 13.32 | 12.55 | 11.62 | 10.98 |
Tangible Book Value | 3,632 | 3,577 | 2,384 | 2,894 | 3,216 | 2,964 |
Tangible Book Value Per Share | 8.63 | 8.50 | 5.70 | 6.92 | 7.70 | 7.14 |
Buildings | - | 3,041 | 2,952 | 586.14 | 585.59 | 627.19 |
Machinery | - | 461.18 | 449.64 | 424.26 | 402.25 | 376.01 |
Construction In Progress | - | 227.31 | 191.87 | 2,037 | 1,448 | 639.67 |